Press Release

PhRMA Statement on Senate Health Care Reform Bill

PhRMA November 19, 2009

Washington, D.C. (November 19, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement about the Senate health care reform bill:

“While we are still reviewing the Senate bill, we remain committed to do our part to make comprehensive health care reform a reality this year. We believe that all Americans should have access to high-quality, affordable health care coverage and services. If done in a smart way, health care reform will benefit patients, the economy and the future of America.

“Compared to the House bill, which would have a chilling effect on medical progress in America, the Senate approach provides a much better blueprint for reform.

“If we are going to cure cancer in our lifetime – as President Obama has challenged us to do – we believe any health reform package must support medical progress and innovation in America. Innovative new medicines have dramatically increased life expectancy rates in America and have allowed patients to live longer, healthier and more productive lives and they have also helped bend the cost curve. Fostering continued medical progress should be a key element of health care reform.

“What’s critical now is that we remain focused on the important goal of helping pass a comprehensive health care reform bill that can get to the President’s desk this year. We will continue to be a constructive partner to help meet this goal.”

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: 

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For more information on public health emergencies, visit:

For information on the danger of imported drugs, visit: